Evosep ApSAktiv
Økonomiske nøgletal
Nøgletal
2025Balancens sammensætning
Selskabsskat
indkomstår 2024Administrationsselskab i en sambeskatning med 1 datterselskaber — tallene gælder hele sambeskatningen.
Kilde: Skattestyrelsens offentlige skattelister for selskaber. Beregnet skat for indkomståret; kan være lavere end 22 % af indkomsten, fx ved skat betalt i udlandet. sktst.dk
Koncernregnskab
2023- Bruttofortjeneste
- 60.178.000 kr.
- Resultat af primær drift
- 20.941.000 kr.
- Årets resultat
- 19.777.000 kr.
- Egenkapital
- 252.714.000 kr.
- Aktiver i alt
- 275.306.000 kr.
- Ansatte
- 42
Tallene ovenfor på siden gælder selskabet alene (modervirksomheden); koncerntallene omfatter også dattervirksomheder.
Regnskabstal2017–2025
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Balance — aktiver | |||||||||
| Likvide beholdninger | 1.948.138 | 12.564.138 | 8.764.520 | 15.699.429 | 20.877.648 | 27.076.936 | 162.458.000 | 161.097.000 | 48.690.000 |
| Omsætningsaktiver i alt | — | — | — | — | 50.423.370 | 101.367.593 | 249.375.000 | 237.767.000 | 152.644.000 |
| Anlægsaktiver i alt | — | — | — | — | 6.344.799 | 10.871.941 | 25.925.000 | 28.150.000 | 20.425.000 |
| Aktiver i alt | 9.631.829 | 24.685.964 | 24.116.053 | 36.957.479 | 56.768.169 | 112.239.535 | 275.300.000 | 265.917.000 | 173.069.000 |
| Balance — passiver | |||||||||
| Kortfristede gældsforpligtelser | — | — | — | — | 10.351.537 | 145.683.478 | 20.173.000 | 13.903.000 | 16.620.000 |
| Langfristede gældsforpligtelser | — | — | — | — | 961.936 | 961.936 | 2.333.000 | 2.125.000 | 1.901.000 |
| Gældsforpligtelser i alt | — | — | — | — | 11.313.474 | 146.645.414 | 22.506.000 | 16.028.000 | 18.521.000 |
| Selskabskapital | 105.555 | 161.838 | 161.838 | 161.838 | 161.838 | 161.838 | 207.000 | 207.000 | 207.000 |
| Overført resultat | 7.122.998 | 22.348.501 | 22.207.305 | 28.376.263 | 45.051.739 | -34.567.718 | 252.507.000 | 249.890.000 | 153.927.000 |
| Årets resultat | -8.613.473 | -4.951.102 | -141.196 | 6.168.958 | 16.675.475 | -79.619.456 | 19.777.000 | -2.613.000 | -221.637.000 |
| Egenkapital i alt | 7.228.553 | 22.510.339 | 22.369.143 | 28.538.101 | 45.213.577 | -34.405.880 | 252.714.000 | 249.889.000 | 154.548.000 |
| Resultatopgørelse | |||||||||
| Bruttofortjeneste | -2.722.228 | 2.509.519 | 9.017.025 | 21.644.268 | 36.908.323 | 53.509.833 | 60.355.000 | 43.124.000 | 72.369.000 |
| Resultat af primær drift | — | — | — | — | 20.872.270 | -110.263.614 | 21.118.000 | -8.602.000 | -238.846.000 |
| EBITDA | — | — | — | — | 21.792.254 | -107.880.362 | 25.957.000 | 278.000 | -228.676.000 |
| Resultat før skat | -11.039.617 | -6.346.438 | -175.763 | 7.851.837 | 21.138.753 | -109.360.575 | 24.008.000 | -3.486.000 | -241.088.000 |
| Årets resultat | -8.613.473 | -4.951.102 | -141.196 | 6.168.958 | 16.675.475 | -79.619.456 | 19.777.000 | -2.613.000 | -221.637.000 |
| Personaleomkostninger | 8.141.720 | 8.763.909 | 9.042.961 | 12.627.349 | 15.116.069 | 154.328.658 | 33.698.000 | 41.962.000 | 277.860.000 |
| Af- og nedskrivninger | 169.178 | 144.357 | 243.935 | 242.003 | 919.984 | 2.383.252 | 4.839.000 | 8.880.000 | 10.170.000 |
| Andre nøgletal | |||||||||
| Ansatte | — | — | — | 13 | 15 | 30 | — | 55 | 60 |
En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.
Om virksomheden
Årsrapport 2025Business reviewThe main activities of the Group include development and marketing of laboratory equipment, including chromatography instruments and associated consumables and other related activities. The current composition of the Group includes Evosep ApS, Evosep Biolabs ApS, Evosep Inc., and Evosep Biolabs Inc.
Financial review In the Annual Report of 2024, we stated that we expected a pre-tax result before tax in the range of mDKK -5 to -1, due to substantial investments into market development and future scalability. 2025 marked a record-breaking year for the Group's commercial performance, with revenue reaching an all-time high — a testament to the continued strong demand for our solutions, the successful execution of our growth strategy as well as the launch of several new products. The Income Statement for 2025 shows a loss before tax of mDKK 241. This result was materially impacted by the cash settlement of warrant agreements, a non-recurring item that weighs significantly on the reported figures. Adjusted for this, the Group's underlying performance exceeded the expectations set out in the prior year's Annual Report. Management considers the adjusted result satisfactory, reflecting deliberate reinvestments in the Group's long-term infrastructure. As of 31 December 2025, the financial position of the company remains strong, and the Balance Sheet reflects an equity of mDKK 155, corresponding to a Solvency Ratio of 89%.
Uddrag af ledelsesberetningen i den seneste årsrapport.